On May 6, 2020, Aimed Alliance hosted a webinar titled “Providing Quality Benefits for Employees with Inflammatory Bowel Disease and…
On May 6, 2020, Aimed Alliance hosted a webinar titled “Providing Quality Benefits for Employees with Inflammatory Bowel Disease and…
On March 31, 2020, Aimed Alliance led an effort to encourage state governors and Medicaid directors to rapidly respond to…
On March 6, 2020, the National Psoriasis Foundation delivered a sign-on letter to the House and Senate sponsors of the…
On January 9, 2020, Aimed Alliance published a report titled “Utilization Mismanagement: Assessing Compliance with Step Therapy and Prior Authorization Laws…
On January 9, 2020, Aimed Alliance published a report titled “Utilization Mismanagement: Assessing Compliance with Step Therapy and Prior Authorization…
On January 2, 2020, Aimed Alliance published a report titled “Utilization Mismanagement: Assessing Compliance with Step Therapy and Prior Authorization…
On November 7, 2019, Aimed Alliance issued a letter of support to the American Medical Association (AMA), voicing support for…
On May 24, 2019, Aimed Alliance Staff Attorney John A. Wylam joined Patient Power founder Andrew Schorr to discuss recent…
When Congress passed the National Defense Authorization Act for Fiscal Year 2018 (NDAA), they gave the Department of Defense (DoD)…
Aimed Alliance is pleased to announce that CMS adopted our recommendations to preserve, rather than weaken, safeguards in place for…